< BACK TO NEWS
negativeSYS.SOURCE: TechCrunch2026-08-20T21:08:34Z

Enhanced Games Venture Ends in $60M Loss for Tech-Backed Biotech Company

The Enhanced Games, a biotech-backed sports event allowing performance-enhancing drugs, resulted in a $60 million loss for the company, marking a commercial failure. The firm is pivoting to a lower-cost online series while the broader peptide industry faces regulatory challenges.

An effort to transform the world of sports through steroid use doesn't exactly seem to be bearing financial fruit.

Read original article

*** END OF TRANSMISSION ***